Canadian Tire Corporation to purchase Helly Hansen for $985 million
Category: #retail  By Pankaj Singh  Date: 2018-05-13
  • share
  • Twitter
  • Facebook
  • LinkedIn

Canadian Tire Corporation to purchase Helly Hansen for $985 million

Canadian Tire Corporation Limited has reportedly announced that it has entered into an agreement to buy Helly Hansen – a leading workwear and sportswear producer based in Oslo, Norway.

Through Mark's and FGL, Canadian Tire Corporation has been dealing with Helly Hansen for long, the firm being one of its largest customers. This acquisition is expected to strengthen the workwear and outdoor categories that are core to Canadian Tire Corporation’s retail banners. It also reinforces the company’s core businesses across several banners, expanding its brand offerings in Canada as well as overseas.

The President and CEO of Canadian Tire Corporation, Stephen Wetmore said that Helly Hansen had been an excellent fit with the company for more than 10 years and the acquisition will considerably strengthen the company’s assortment across all its banners. He added that with Helly Hansen’s recognition as a trusted global brand combined with the capabilities of Canadian Tire Corporation, opportunities will be immense for both the companies.

Reliable resources quote Paul Stoneham, CEO, Helly Hansen to have said that the platform that Canadian Tire Corporation can provide Helly Hansen can accelerate the growth trajectory of the company.

Founded in 1877, Helly Hansen is regulated by the Ontario Teachers' Pension Plan and is known for the professional grade gear it produces. Helly Hansen is also a leader in designing high quality and innovative products for technical performance in the harshest outdoor conditions. The company designs and delivers products like sailing, mountaineering, skiing, rain gear and workwear for outdoor enthusiasts and professionals across the world. Having retail and wholesale distribution capabilities across 40 countries, Helly Hansen is a celebrated brand all over the world.

The purchase agreement has been finalized at $985 million with an assumption of approximately $50 million of operating debt. The acquisition is expected to be finalized in the third quarter of 2018.



About Author

Pankaj Singh

Email: [email protected]   

Pankaj Singh

Pankaj Singh Develops content for Market Size Forecasters, Algosonline, and a couple of other platforms. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his field of profession. With exp...

Read More

More News By Pankaj Singh

Anova Enterprises expands AnovaOS™ to boost clinical development
Anova Enterprises expands AnovaOS™ to boost clinical development
By Pankaj Singh

The U.S-based Anova Enterprises, Inc. (Anova) has reportedly expanded the AnovaOS™ technology platform in order to boost the development of promising novel treatments. The platform brings pharmaceutical companies...

Serum Institute to Resume Oxford COVID-19 Vaccine’s Trail in India
Serum Institute to Resume Oxford COVID-19 Vaccine’s Trail in India
By Pankaj Singh

India’s Drugs Controller General (DCGI) has approved Pune-based Serum Institute of India (SII) to restart the clinical trial of the Oxford/AstraZeneca COVID-19 vaccine in India.

Everest Medicines Announces Cefepime-Taniborbactam Phase 1 Results

Everest Medicines Announces Cefepime-Taniborbactam Phase 1 Results
By Pankaj Singh

Everest Medicines announced the top-line results from the Phase 1 clinical trial of Taniborbactam with cefepime for treating infections caused by multi-drug resistant pathogens in China. Everest Medicines is a biopharm...